Sign in / Join Now
ETFs & Funds
Why I Have Re-Entered Sarepta Therapeutics $
Add a reply...
Latest StockTalks »
people get SRPT breaking news and analysis by email alert.
Get email alerts on SRPT »
Sarepta Therapeutics, Inc.
Get latest price
From other sites
For Sarepta, Exondys 51 Might Be Just The Beginning: Credit Suisse Starts At Outperform
at Benzinga (Tue, 9:56AM)
Exclusive: SunTrust Managing Director Goes Over Sarepta Therapeutics' Story
at Benzinga (Mon, 8:49AM)
Short Interest In Sarepta Therapeutics Moves 21% Lower
at Nasdaq.com (Oct 13, 2016)
Wedbush Boosts Target On Sarepta Shares From $66 To $72 Amid US Launch Of Exondys 51
at Benzinga (Oct 10, 2016)
Sarepta (SRPT) Stock Closed Down, Baird: Anthem Policy Doesn't Mean Coverage Denied
at TheStreet (Oct 7, 2016)